RE:RE:RE:RE:RE:RE:RE:RE:RE:SHRMF Back from dead?
I was saying this was going to the deep end late March at $1.85 due to their current financial status. All i recieved was rederict from people too emotionally attached to their investments. At .89 their market cap is $70m with no reason to believe it's even worth that much. They most certainly have potential but are far(years away)from being worth even that much of value. They barely have any income. In the future they might, but that requires so much more progress that currently isnt materializing(that we are aware of). Considering how expensive their treatments will be, and who knows if any government funds will help assist patients in these treatments, covid will only be a set back. People can't afford >1.5k a treatment. This company does have potential and i think the legalization of medicinal psychedelics has the potential to truly be a game changer. This company has a long way to go before they can make any ground financially(which will ultimately bring shareholder value). I would love to invest in this sector but i fail to see any potential profits with ketamine, or psilocybin possibly until the 2030's.